Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares shot up 18.4% during trading on Tuesday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). 4,184,618 shares were traded during mid-day trading, an increase of 135% from the average session volume of 1,782,671 shares. The stock had previously closed at GBX 1.60 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a fifty day simple moving average of GBX 1.80 and a 200-day simple moving average of GBX 1.85. The company has a market capitalization of £7.51 million, a PE ratio of -189.50 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- Low PE Growth Stocks: Unlocking Investment Opportunities
- NVIDIA is Still the Most Important Stock in the Market
- Investing In Automotive Stocks
- 2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
- Best Stocks Under $5.00
- Will Berkshire Hathaway Continue to Dominate in 2025?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
